YM-254890
YM-254890[edit | edit source]
YM-254890 is a naturally occurring cyclic depsipeptide that acts as a potent and selective inhibitor of the G_q protein. It was originally isolated from the culture broth of the bacterium Chromobacterium sp. QS3666. YM-254890 has garnered significant interest in the field of pharmacology due to its potential therapeutic applications in diseases where G_q signaling is implicated.
Chemical Structure[edit | edit source]
YM-254890 is characterized by its complex cyclic structure, which includes both peptide and ester linkages, classifying it as a depsipeptide. The molecule's unique configuration allows it to bind specifically to the G_q subunit, inhibiting its interaction with downstream effectors.
Mechanism of Action[edit | edit source]
YM-254890 exerts its effects by binding to the G_q protein, a member of the G protein family involved in transducing signals from G protein-coupled receptors (GPCRs) to intracellular pathways. By inhibiting G_q, YM-254890 effectively blocks the signaling cascade that leads to the activation of phospholipase C, thereby reducing the production of inositol trisphosphate (IP3) and diacylglycerol (DAG). This inhibition can modulate various physiological processes, including smooth muscle contraction, platelet aggregation, and cell proliferation.
Potential Applications[edit | edit source]
The selective inhibition of G_q by YM-254890 presents potential therapeutic applications in conditions such as hypertension, heart failure, and certain types of cancer. By modulating G_q-mediated pathways, YM-254890 could offer a novel approach to treating diseases characterized by dysregulated G protein signaling.
Research and Development[edit | edit source]
Ongoing research is focused on understanding the full spectrum of YM-254890's biological effects and its potential as a lead compound for drug development. Studies are exploring its efficacy and safety in various animal models and its potential synergistic effects with other therapeutic agents.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
